Loading...
You are here:  Home  >  Health
Latest

India grants Pfizer patent on pneumonia vaccine in blow to aid group

/  22.08.2017  /  Health 

MUMBAI (Reuters) – India has granted Pfizer Inc a patent for its powerful pneumonia vaccine Prevenar 13, in a blow to some health groups that said this would put the treatment out of reach of thousands in poorer nations.

Read More →
Latest

Philip Morris International CEO cheers U.S. FDA tobacco proposal

/  22.08.2017  /  Health 

(Reuters) – The chief executive of Philip Morris International said he was “extremely encouraged” by the U.S. Food and Drug Administration’s recent proposal to lower nicotine levels in cigarettes and nudge smokers toward less harmful alternatives such as e-cigarettes.

Read More →
Latest

J&J ordered to pay $417 million in trial over talc cancer risks

/  21.08.2017  /  Health 

(Reuters) – Johnson & Johnson on Monday was ordered by a California jury to pay $417 million to a woman who claimed she developed ovarian cancer after using the company’s talc-based products like Johnson’s Baby Powder for feminine hygiene.

Read More →
Latest

Shire’s CFO resigns to join plant technology start-up

/  21.08.2017  /  Health 

LONDON (Reuters) – Pharmaceutical company Shire said its chief financial officer Jeff Poulton will stand down at the end of the year to join Indigo Ag, a Boston-based start-up that seeks to improve agricultural productivity.

Read More →
Latest

Britain’s Creo receives speedy FDA approval for its endoscopic device

/  21.08.2017  /  Health 

LONDON (Reuters) – Britain’s Creo Medical Group said its device to remove cancerous lesions in the bowel during an endoscopy had received U.S. approval much quicker than it planned, shaking up a timetable that had been focused on a European launch.

Read More →
Latest

AstraZeneca ups investment in messenger RNA drugs with Ethris deal

/  21.08.2017  /  Health 

FRANKFURT (Reuters) – AstraZeneca has stepped up its investment in messenger RNA drugs, a promising approach in genetic therapy, by spending more than 25 million euros ($29 million) on a research alliance with German biotech start-up Ethris.

Read More →
Latest

New Novartis drug takes aim at tough-to-treat malaria

/  21.08.2017  /  Health 

LONDON (Reuters) – Novartis is taking aim at drug-resistant malaria – a growing global problem – by launching clinical trials of the first new antimalarial medicine for many years in nine countries across Africa and Asia.

Read More →
Latest

Bayer, J&J win third U.S. trial over Xarelto bleeding risk

/  19.08.2017  /  Health 

(Reuters) – A federal jury has cleared Bayer AG and Johnson & Johnson of liability in the third case to go to trial out of thousands of lawsuits claiming the drugmakers’ blood thinner Xarelto led to severe internal bleeding.

Read More →
Latest

Insys agrees to pay $4.45 million to resolve Illinois opioid lawsuit

/  18.08.2017  /  Health 

BOSTON (Reuters) – Insys Therapeutics Inc has agreed to pay $4.45 million to resolve a lawsuit by Illinois’ attorney general claiming it deceptively marketed an addictive fentanyl-based cancer pain drug for off-label uses.

Read More →
Latest

Exclusive: India threatens Philip Morris with ‘punitive action’ over alleged violations

/  18.08.2017  /  Health 

NEW DELHI (Reuters) – The Indian government has threatened Philip Morris International Inc with “punitive action” over the tobacco giant’s alleged violation of the country’s anti-smoking laws, according to a letter sent to the company by the federal health ministry.

Read More →